|Articles|June 29, 2022
Evaluating new atopic dermatitis medications for children
Author(s)Lois Levine, MA
At the 2022 Maui Derm NP+PA meeting in Colorado Springs, Colorado, a discussion of the newest biologics and how to "mix and match" medications and algorithms.
Advertisement
Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego, professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discussed the evaluation and use of new medications for atopic dermatitis for children, and how you need to "mix and match" biologics and alogrithms for optimal results.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
ACIP dropped MMRV coverage. New data show it was a lifeline for VFC-eligible kids
2
FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events
3
FDA accepts sNDA for vosoritide in children with achondroplasia
4
Infliximab and adalimumab show comparable infection risk in pediatric IBD
5